Records containing: Neuroendocrine Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-09-24(STM-03) Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
-
CLINICAL_TRIALS study record update · 2020-09-10IMMUNeOCT Study: Octreotide LAR in the Induction of Immunologic Response in Patient With Neuroendocrine Tumors: an Interventional Pharmacological Study
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase II Trial of Mutation-Targeted Therapy With Sunitinib or Everolimus in Patients With Advanced Low-or Intermediate Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery
-
CLINICAL_TRIALS study record update · 2020-09-09Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors: a First-in-human PET/CT Study
-
CLINICAL_TRIALS study record update · 2020-08-28Observational Study on Perception of Information and Quality of Life in Neuroendocrine Tumor on Lanreotide Autogel
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-08-20CalliSpheres Drug-Eluting Beads With Oxaliplatin to Treat Inoperable NET Liver Metastases: A Multi-center Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-07-2768Ga-DOTATATE Imaging in Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2020-07-27A Phase II Study to Assess the Activity and Safety of TH-302 in Combination With Sunitinib in Treatment-naïve Patients With Well- and Moderately-differentiated Metastatic Pancreatic Neuroendocrine Tumours (pNET)
-
CLINICAL_TRIALS study record update · 2020-06-22Positron Emission Tomography (PET) Imaging of Patients With Low & Intermediate Grade Neuroendocrine Tumors Using 64Cu-SARTATE: A Single Centre, Open-Label, Non-Randomized, Phase-0 Microdosing Investigation
-
CLINICAL_TRIALS study record update · 2020-06-17Adjuvant Hepatic Holmium-166-radioembolization in Patients With Unresectable Liver Metastases of Neuroendocrine Origin, Who Have Been Treated With Lutetium-177-dotatate
-
CLINICAL_TRIALS study record update · 2020-06-02A Multicenter, Retrospective, Medical Record Review Of The Effectiveness Of Lanreotide Following Treatment With Octreotide In Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2020-04-28The Patient's Journey - Assessing the Time to Final Diagnosis in Patients With Neuroendocrine Tumors (NET) in Western Sweden
-
CLINICAL_TRIALS study record update · 2020-04-07Vascular Resection During Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms (PanNENs): a Comparative Single Centre Study
-
CLINICAL_TRIALS study record update · 2020-04-01Clinical Study of the Use of Yttrium-90 (90Y) and/or Lutecium-177 (177Lu) DOTATATE (DOTA-0-Tyr3-Octreotate) in the Treatment of Disseminated and / or Symptomatic Tumors With Somatostatin Receptor Overexpression
-
CLINICAL_TRIALS study record update · 2020-03-09Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM01183 in Combination With Doxorubicin in Non-heavily Pretreated Patients With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-03-05Studio Esplorativo Monocentrico Non Controllato, in Aperto, Volto a Sviluppare e Valutare l'Applicazione di Una Tecnica Innovativa di Rimozione Radioguidata Dei Tumori Neuroendocrini Gastro-entero-pancreatici
-
CLINICAL_TRIALS study record update · 2020-02-07Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
-
CLINICAL_TRIALS study record update · 2020-01-27Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma
-
CLINICAL_TRIALS study record update · 2020-01-23SwissNET - a Prospective Registry of Patients With Neuroendocrine Tumours in Switzerland
-
CLINICAL_TRIALS study record update · 2019-11-14Efficacy of Peptide Receptor Radionuclide Therapy for Metastatic Inoperable Neuroendocrine Tumors Using 177-Lu-DOTA 0, Tyr 3 Octreotate
-
CLINICAL_TRIALS study record update · 2019-11-06Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
-
CLINICAL_TRIALS study record update · 2019-11-06Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2019-10-25Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation A Prospective Interventional Trial of Patients With Neuro-endocrine Tumors With Carcinoid Syndrome Receiving Octreotide LAR
-
CLINICAL_TRIALS study record update · 2019-09-30A Multicenter Phase II-Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2019-09-24Resection of Metastatic Pancreatic Neuroendocrine Tumors After Induction System Treatment: Real World Study